Remove 2022 Remove Clinical Development Remove Licensing Remove Pharma Companies
article thumbnail

Drug discovery hotspots: What is the secret to Switzerland’s success? (p1)

Drug Discovery World

So, in this way there is a cross fertilisation from the bigger companies to newer ones. Start-ups will also take drug candidates from the pharma companies that are not getting attention for one reason or another and develop those into viable commercial products.” References [link] [link].

Science 148
article thumbnail

Taking a new approach to tackle neurodegenerative diseases

Drug Discovery World

million in 2022 to 12.7 Several of the large pharma companies have recently re-entered the dementia field. Diseases such as PSP and FTD have no licensed and available treatments. Volume 23 – Issue 4, Fall 2022. is President, Head of Development & Operations of Oligomerix. million by 2050.” .

Disease 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Europe: Where is the drug discovery innovation?

Drug Discovery World

The oldest, still active pharmaceutical company worldwide, Merck, started life in 1668 in Darmstadt, Germany. In 2022, the continent held a 22.4% share of global pharma revenues, according to analysts Statistica 1. So, in this way there is a cross fertilisation from the bigger companies to newer ones.

Drugs 148
article thumbnail

European Commission vs Big Pharma, or profit vs access?  

Drug Discovery World

Antibiotic development According to Politico, the European Medicines Agency is investigating a chronic shortage in antibiotics across Europe, where almost every country is reporting gaps in supplies – 25 out of the 27 EU countries have reported local shortages, the agency’s Chief Medical Officer, Steffen Thirstrup, told a press briefing 6.

article thumbnail

Where is the drug discovery expertise happening in the UK?

Drug Discovery World

Dr Tralau-Stewart says: “Indeed, many academic institutions have established new ways of supporting the discovery pipeline, providing tech transfer offices to support licensing, and entrepreneurship and start-up support through fundraising, accelerators, and incubators.

Drugs 190